Description
B/T CLPD evaluation
CLPD Panel-CD5,CD23,CD19,CD3,CD22,CD20,CD10,FMC7,CD79b,CD38, CD103, CD25, Kappa, Lambda
B/T CLPD evaluation
TAT:
Specimen Type:
Flowcytometry Panel Test
Other Tests
-
231%
CD 34
CD34+ cell quantification is necessary to determine the optimal timing and to confirm the adequacy of Peripheral Blood Stem Cell (PBSC) harvests. This assay also helps to determine when to perform Bone marrow stem cell transplants; whether to continue Apheresis and to assess bone marrow and Cord blood viability. CD34+ absolute count is a critical parameter for rapid and sustained engraftment.
CD 34
CD34+ cell quantification is necessary to determine the optimal timing and to confirm the adequacy of Peripheral Blood Stem Cell (PBSC) harvests. This assay also helps to determine when to perform Bone marrow stem cell transplants; whether to continue Apheresis and to assess bone marrow and Cord blood viability. CD34+ absolute count is a critical parameter for rapid and sustained engraftment.
-
233%
CD34 AND CD3 CELL COUNT – HARVEST SAMPLE (HRVST)
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.
CD34 AND CD3 CELL COUNT – HARVEST SAMPLE (HRVST)
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.
-
238%
CLPD panel-1 CD5,,CD23,CD19,CD3,CD10,CD79b,CD38,CD200, Kappa, Lambda
Kappa,Lamda,CD38,19,45,5,10,20,3,4,5,7,56,200,23,43,49d,FMC-7, Additiional CD103,123,25,11c
CLPD panel-1 CD5,,CD23,CD19,CD3,CD10,CD79b,CD38,CD200, Kappa, Lambda
Kappa,Lamda,CD38,19,45,5,10,20,3,4,5,7,56,200,23,43,49d,FMC-7, Additiional CD103,123,25,11c
-
233%
CD4/CD8 Count
Reflection of immune system health
Reviews
There are no reviews yet.